TLS may be asymptomatic in the early stages, and by the time symptoms appear it can be life threatening.

The aim is to identify all patients at risk of TLS and manage them appropriately prior to the development of the clinical syndrome. Although a detailed history and examination are important, the definitive diagnosis of TLS is based on blood biochemistry.

BMJ Best Practice is an evidence-based point of care tool for healthcare practitioners.

To continue reading and access all of BMJ Best Practice's pages you'll need to log in or start a free trial.

You can access through your institution if your hospital, university, trust or other institution provides access to BMJ Best Practice through either OpenAthens or Shibboleth.

Use of this content is subject to our disclaimer